Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a “vaccinal effect” of rituximab

The incorporation of rituximab, a chimeric anti-CD20 monoclonal antibody, into the therapeutic armamentarium for patients with follicular lymphoma (FL) has significantly improved treatment outcome for such patients. Despite the almost universal application of this therapy, however, its exact mechani...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hilchey, Shannon P., Hyrien, Ollivier, Mosmann, Tim R., Livingstone, Alexandra M., Friedberg, Jonathan W., Young, Faith, Fisher, Richard I., Kelleher, Raymond J., Bankert, Richard B., Bernstein, Steven H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2009
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2670795/
https://ncbi.nlm.nih.gov/pubmed/19196657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-10-185280
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados